PCOS (Polycystic Ovarian Syndrome) Patients
Prospective Cohort Study for PCOS Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)
1 other identifier
observational
10,000
1 country
1
Brief Summary
The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 13, 2019
CompletedFirst Posted
Study publicly available on registry
June 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2050
June 19, 2019
June 1, 2019
41 years
June 13, 2019
June 18, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Level of serum FSH (Follicle stimulating hormone)
mIU/mL
From date of inclusion, assessed by each 12 month, up to 40 years
Level of serum LH (Luteinizing hormone)
mIU/mL
From date of inclusion, assessed by each 12 month, up to 40 years
Level of T (Testosterone)
ng/ml
From date of inclusion, assessed by each 12 month, up to 40 years
Secondary Outcomes (2)
Body Weight
From date of inclusion, assessed by each 12 month, up to 40 years
Height
From date of inclusion, assessed by each 12 month, up to 40 years
Eligibility Criteria
PCOS patients diagnosed with The Rotterdam diagnostic criteria.
You may qualify if:
- PCOS patients diagnosed with The Rotterdam diagnostic criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
Biospecimen
Blood sample
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Reproductive Medical Center
Study Record Dates
First Submitted
June 13, 2019
First Posted
June 19, 2019
Study Start
January 1, 2010
Primary Completion (Estimated)
December 31, 2050
Study Completion (Estimated)
December 31, 2050
Last Updated
June 19, 2019
Record last verified: 2019-06